QbD Model for Clinical Trials Could Cut Costs

The FDA is working on developing a quality-by-design (QbD) model for clinical trials that would cut monitoring costs.  The  plan is to implement the model within the next 25 years.  There is already a QbD model is place for manufacturing that allows for the quality production each and every time and that is what the FDA is searching for with clinical trials.   The push for a new model to monitor clinical trials is to develop a better infrastructure for how the trails are regulated and conducted.  To read more about this topic, go here.